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otivation
a  b  s  t  r  a  c  t
“Food  addiction”  has  become  a focus  of interest  for  researchers  attempting  to  explain  certain  processes
and/or  behaviors  that may  contribute  to the development  of  obesity.  Although  the scientiﬁc  discussion
on  “food  addiction”  is  in  its nascent  stage,  it has  potentially  important  implications  for  treatment  and
prevention  strategies.  As such,  it is important  to  critically  reﬂect  on the appropriateness  of the  term  “food
addiction”,  which  combines  the concepts  of  “substance-based”  and  behavioral  addiction.  The  currently
available  evidence  for a substance-based  food  addiction  is poor,  partly  because  systematic  clinical  and
translational  studies  are  still  at an early  stage.  We  do  however  view  both  animal  and existing  human  data
as consistent  with  the existence  of addictive  eating  behavior.  Accordingly,  we  stress  that  similar  to  other
behaviors  eating  can become  an addiction  in thus  predisposed  individuals  under  speciﬁc  environmental
circumstances.  Here,  we  introduce  current  diagnostic  and  neurobiological  concepts  of substance-related
and  non-substance-related  addictive  disorders,  and  highlight  the  similarities  and  dissimilarities  betweenat addiction
ugar addiction
alt addiction
ddictive disorders
addiction  and overeating.  We  conclude  that  “food  addiction”  is a misnomer  because  of the  ambiguous
connotation  of  a substance-related  phenomenon.  We  instead  propose  the  term  “eating  addiction”  to
underscore  the  behavioral  addiction  to eating;  future  research  should  attempt  to  deﬁne  the diagnostic
criteria  for  an eating  addiction,  for  which  DSM-5  now  offers  an umbrella  via  the  introduction  on  Non-
Substance-Related  Disorders  within  the  category  Substance-Related  and Addictive  Disorders.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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. Introduction
Almost 60 years ago, Randolph ﬁrst deﬁned “food addiction”
s “[. . .]  a speciﬁc adaptation to one or more regularly consumed
oods to which a person is highly sensitive, produces a com-
on  pattern of symptoms descriptively similar to those of other
ddictive processes”; addictive-like consumption of corn, wheat,
offee, milk, eggs, and potatoes was reported (Randolph, 1956).
ith the increase in the worldwide prevalence of obesity over the
ast decades (Finucane et al., 2011; Ogden et al., 2012) the con-
ept of “food addiction” has recently become popular both among
esearchers and the lay public as a possible way to understand the
mpact of psychological factors on weight gain (Brownell and Gold,
013). This concept forms an etiological framework that is centered
etween chemical or “substance based” and behavioral addictions.
The rise in prevalence rates of obesity in many countries can-
ot be attributed to genetic factors alone; instead, environmental
hanges, which interact with our biological make-up, appear to
nderlie the obesity pandemic. A large proportion of different
opulations overeat to an extent that threatens physical and mental
ell-being, and both somatic and psychiatric disorders are associ-
ted with obesity. “Food addiction” offers a superﬁcially attractive
xplanation, and potentially an excuse, for this unhealthy behav-
or at an individual level. The modern “obesogenic” environment is
haracterized by the ubiquitous availability of palatable, energy-
ense and inexpensive foods, reﬂecting ongoing efforts of the
lobalized food industry to increase production and boost sales. As
uch, the food and beverage industry is perceived as having a pow-
rful role in promoting poor nutrition policies (Davis, 2013). “Food
ddiction” places blame on the food industry for the production of
addictive foods” and by so doing indicates that obesity prevention
trategies should seek to curtail the inﬂuence of this industry on
ating behavior.
The behavioral, clinical and neurobiological similarities and dis-
imilarities between addiction and overeating are highlighted in
his review. We  point out that current evidence in humans suggests
hat “eating addiction” rather than “food addiction” more precisely
ircumscribes addictive-like food intake in affected individuals.
. Deﬁnition, classiﬁcation, and neurobiology of addiction
.1. Deﬁnition of addiction and classiﬁcation of substance-related
nd addictive disorders
An overarching scientiﬁc delineation of the concept of addiction
as proven elusive: “Ideally, we would like to discover the neces-
ary and sufﬁcient conditions for someone to have an addiction,
nd to do so in such a way as to provide real illumination about the
ort of phenomena we have in mind when thinking about addic-
ion” (Sussman and Sussman, 2011). Clinicians and researchers
nderstand addiction in several different ways. Drug addiction has
een deﬁned as a chronically relapsing disorder characterized by
1) compulsion to seek and take the drug, (2) loss of control in . .  .  . . . . . . . .  .  . . . . . . .  .  . . .  . .  . . .  . .  . . .  .  .  . . .  . . . .  .  . . . . . . .  .  .  . .  .  .  .  . .  . . .  .  . . . . . .  .  . .  .  304
limiting drug intake, and (3) emergence of a negative emotional
state (e.g., dysphoria, anxiety and irritability) reﬂecting a motiva-
tional withdrawal syndrome when access to the drug is prevented;
Koob (2013) refers to the term ‘reward deﬁcit disorder’ for alco-
holism and other drug addictions, which are based on multiple
motivational mechanisms and progress from impulsivity (positive
reinforcement) to compulsivity (negative reinforcement). Compul-
sive drug seeking can be derived from multiple neuroadaptations.
Koob stresses that a key component of addiction is based on the
construct of negative reinforcement deﬁned as drug taking that
alleviates a negative emotional state. This state is hypothesized to
result from the dysregulation of speciﬁc neurochemical elements
involved in reward and stress within the basal forebrain structures
(Koob, 2013).
Sussman and Sussman (2011) identiﬁed ﬁve elements of addic-
tion that recur in the scientiﬁc literature: (1) engagement in the
behavior to achieve appetitive effects; (2) preoccupation with the
behavior; (3) temporary satiation; (4) loss of control; and (5) suffer-
ing negative consequences. They point out the major limitations of
conceptualizing addiction via these deﬁnitional elements. In par-
ticular, there are difﬁculties in measuring these elements, which
might not be independent, but rather related and operative in com-
plex feedback loops. It is also unclear to what quantitative extent
‘engagement’ must be present before it can be labeled as addic-
tive behavior. Finally, what is perceived as an addiction might be
context-dependent.
Until recently, the medically established forms of addic-
tion (APA, 2000) pertained to substance-related disorders only:
“Addiction is deﬁned as a chronic, relapsing brain disease that
is characterized by compulsive drug seeking and use, despite
harmful consequences” (National Institute on Drug Abuse, 2013).
Substance-related disorders, which represent a major global pub-
lic health problem (Whiteford et al., 2013), are classiﬁed within the
context of mental disorders in the widely used Tenth Edition of the
International Classiﬁcation of Diseases (ICD-10) and the Fifth Edi-
tion of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5; APA, 2013).
The now outdated DSM-IV TR (APA, 2000) avoided the diagnos-
tic use of the term addiction and instead referred to the category
“Substance-Related Disorders”,  subdivided into Substance Use Disor-
ders and Substance Induced Disorders (Table 1). Within Substance
Use Disorders, Substance Dependence referred to “a cluster of cogni-
tive, behavioral, and physiological symptoms”. If diagnostic criteria
for Substance Dependence were not met, but a “maladaptive pattern
of substance use manifested by recurrent and signiﬁcant adverse
consequences related to the repeated use of substances” applied,
Substance Abuse was diagnosed.
After extensive discussions of the deﬁnition of the term “addic-
tion”, the DSM-5 Substance Use Disorders Workgroup re-titled the
previous category as “Substance-Related and Addictive Disorders”
(APA, 2013; Table 1), which was subdivided into “Substance-Related
Disorders” and “Non-Substance-Related Disorders”. Importantly,
within the context of Substance-Related Disorders, ‘addiction’ is
J. Hebebrand et al. / Neuroscience and Biobehavioral Reviews 47 (2014) 295–306 297
Table  1
The transistion from DSM-IV to DSM-5; the novel diagnostic category ‘Substance-Related and Addictive Disorders’ in DSM 5 for the ﬁrst time allows the diagnosis of
Non-Substance-Related Disorders.
DSM-IV TR (APA, 2000) DSM 5 (APA, 2013)
Substance Related Disorders Substance-Related and Addictive Disorders
Substance Use Disorders Substance Induced Disorders Substance-Related Disorders Non-Substance-Related Disorders
n
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ot applied as a diagnostic term. Instead, “the more neutral term
ubstance Use Disorder is used to describe the wide range of the dis-
rder, from a mild form to a severe state of chronically relapsing,
ompulsive drug taking” (APA, 2013). The DSM-IV subdivision of
ubstance use disorders into ‘dependence’ and ‘abuse’ was dropped,
ecause the evidence for this distinction was considered to be insuf-
cient.
Because gambling behaviors activate similar reward systems
hat are targeted by drugs of abuse, and because they produce
ehavioral symptoms that overlap with those produced by Sub-
tance Use Disorders, Gambling Disorder was included as the sole
on-Substance-Related Disorder in DSM-5 (APA, 2013). The evidence
or including other behavioral addictive disorders such as Internet
aming, sex addiction or shopping addiction appeared too weak.
or similar reasons, obesity was not included in DSM-5, despite
he importance of behavior and the involvement of the same cen-
ral pathways that are involved in substance use disorders (Volkow
nd O‘Brien, 2007).
The inclusion of Non-Substance-Related Disorders within the
ewly titled category ‘Substance-Related and Addictive Disorders’
n DSM 5 represents a paradigm shift, which will also potentially
nﬂuence ICD-11. The term addictive disorder has entered the psy-
hiatric classiﬁcation system, albeit not (yet) as an umbrella term
or both substance use and behavioral addiction. The door is thus
ow open for the future inclusion of other behavioral addictions
nto the diagnostic classiﬁcation schemes.
.2. Overlap and distinction between exogenous and endogenous
ubstances and between chemical and behavioral addiction
A classic ﬁnding in the context of addiction was that substance
isuse can alter central nervous system signaling involving pep-
ides with rewarding properties, such as enkephalins, endorphins,
nd cannabinoids (Feng et al., 2012; Mechoulam and Parker, 2013).
owever, changes in these endogenous signals can also be asso-
iated with non-substance-based addictive behavior. Hence, the
eneral term “chemical addiction” does not necessarily require the
ubstance to be an exogenous chemical. Different receptor genes
re expressed in different parts of the brain, conferring the ability
o bind these endogenous substances with high afﬁnities. The vari-
us systems are each involved in a host of diverse functions–many
f which are completely unrelated to reward processes. However,
f endogenous “chemicals” can be rewarding or by their actions
t speciﬁc brain sites in some circumstances and/or in predis-
osed individuals, such neural mechanisms might represent a link
etween drug and behavioral addiction. Accordingly, the link of
ppetite, hunger, satiation and satiety with the reward system
Bellisle et al., 2012) can be viewed as a basis for the development
f addictive-like eating behavior. Psychological cues like bore-
om, perceived stress or a negative mood potentially may  trigger
vereating in the absence of hunger that would lead to neurobio-
ogical alterations in complex central regulatory systems related to
ddictive behaviors.
Structural differences between endogenous and exogenous sub-
tances of, for example, the opioid agonists result in differentSubstance Use Disorder Gambling Disorder
conformational, topographical, and stereoelectronic presentations
(Hruby and Agnes, 1999) toward the opioid receptors. “Agonist-
selective” regulation of opioid receptors is well known (Williams
et al., 2013) and entails different signaling efﬁcacies (Kelly, 2013)
to multiple downstream pathways and differences in the ability to
induce opioid receptor internalization, tolerance and dependence
(Koch and Höllt, 2008). Subtle structural modiﬁcations, inde-
pendent of the structural class (opioid peptide based, morphine
based, or 4-anilinopiperidin-4-carboxamid [e.g. fentanyl] based)
can have a strong impact on the formation of the functional
receptor complex and modify efﬁcacy and tolerance development
(Stafford et al., 2001); the mechanisms underlying this func-
tional diversity are poorly understood (Williams et al., 2013). The
strength of the impact depends strongly on the observable intrin-
sic efﬁcacy of the ligand/drug and not as much on the structural
class or their exogenous or endogenous origin (Williams et al.,
2013).
Endogenous “chemicals” similar to neurotransmitters are
released within normal physiological concentrations during vari-
ous activities (e.g. physical exercise, sexual stimulation), but still
may  eventually lead to a behavioral adaptation accompanied by
signs of tolerance and withdrawal in thus predisposed individ-
uals under speciﬁc circumstances. In contrast, exogenous drugs
can result in responses that are quantitatively and/or qualitatively
beyond those experienced in normal physiology.
The route of administration (e.g. inhalation, oral intake, intra-
venous injection) of an exogenous substance can also determine
its addictive properties, for example, the impact of heroin’s route of
administration on its withdrawal severity is marked, due to differ-
ences in bioavailability (Smolka and Schmidt, 1999). In the context
of food, it is noteworthy that intravenous infusion of glucose can
support conditioning and cause dopamine release in the nucleus
accumbens (as do drugs of abuse). However, the effect seems more
robust when glucose is administered either in the intestinal tract or
in the hepatic-portal vein (Ackroff et al., 2010; Oliveira-Maia et al.,
2011).
On a symptomatic level, individuals with behavioral or sub-
stance addictions have the urge to engage in their behavioral
routine; they feel discomfort if they cease their use, which results
in craving and withdrawal symptoms. Some withdrawal symptoms
(e.g. anxiety) are common across certain behavioral and chemical
addictions, while others (e.g. runny eyes and sneezing in opiate
withdrawal) are substance-speciﬁc (Morrissey et al., 2008; Bradley,
1990).
Eating is intrinsically rewarding and reinforcing, and food con-
sumption is well-known to activate the reward system in the brain;
this applies particularly in the physiological state of hunger. It is
easy to see that the rewarding properties of food and their acti-
vation of the reward pathway might lead intuitively to the idea
that food substances may  have addictive properties. However, just
because eating behavior engages these reward systems, it does not
necessarily follow that speciﬁc nutrients (substances) are able to
evoke a substance addiction. Instead, the complex activation of the
reward system as the initial step of the process ending in addic-
tion can be viewed as being dependent on eating (subjectively)
2  Biobe
p
s
2
i
c
c
2
b
s
d
v
c
c
i
F
n
s
e
m
b
r
r
a
t
s
w
c
C
b
t
s
t
w
s
b
t
I
l
b
a
s
m
a
(
a
s
b
d
o
m
d
r
s
i
e
i
t
e
V
e98 J. Hebebrand et al. / Neuroscience and
alatable foods irrespective of their nutritional/chemical compo-
ition.
.3. Neurobiology of the reward pathways and the overlap and
nteraction between homeostatic and hedonic circuits
Feeding behavior is mediated by a network of interacting neural
ircuits that include the hypothalamus, the dorsolateral prefrontal
ortex (DLPFC), amygdala, striatum and the midbrain (Berthoud,
011). Together these systems regulate all aspects of feeding
ehavior, including both homeostatic food consumption (i.e. con-
umption governed by signals relating to energy stores and energy
emands), and hedonic food consumption (i.e. consumption moti-
ated by reward systems). These homeostatic and hedonic neural
ircuits do not operate independently of one another: they are
losely interlinked, and both respond to metabolic signaling. Insight
nto these neural circuits is leading to novel treatment strategies.
or example, a recent meta-analysis concluded that non-invasive
euro-stimulation of the DLPFC is effective in decreasing craving in
ubstance dependence and craving for highly palatable food (Jansen
t al., 2013).
Here we outline the putative pathways through which
etabolic and reward signals can interact to produce feeding
ehavior. This serves as a framework for understanding the neu-
obiological underpinnings of motivation for food and the possible
outes by which feeding history can inﬂuence behaviors linked to
ddiction.
Speciﬁc neurobiological systems drive attentional and motiva-
ional behavior toward important environmental stimuli. Animals
how a motivation to ﬁnd and consume food, which is contrasted
ith the sensory pleasure of actually eating (in 1996 Berridge
oined the terms wanting and liking for these two  phenomena).
ontextual cues or behaviors related to the initial reinforcer can
ecome more important in maintaining the increasingly addic-
ive behavior than the primary stimulus itself. Primary reinforcers,
uch as sweet foods, or the environmental cues associated with
hem, can become increasingly salient as the pleasure associated
ith their consumption is learned. With repeated exposure, this
alience increases, and their prominence as a stimulus to drive
ehavior becomes greater (Volkow et al., 2013). This may  lead to
he overconsumption of foods for which there is no metabolic need.
t has been argued that this increase in the salience of food paral-
els the development of addiction to drugs of abuse, particularly
ecause it shares a common neurobiological pathway mediating
ltered reward salience and motivation – the mesolimbic dopamine
ystem. A subgroup of individuals who, for various reasons, are
ore “cue reactive” in (i.e. certain reward cues are more likely to
ttract these individuals), will be more motivated to obtain rewards
Saunders and Robinson, 2013).
Dopamine signaling plays a pivotal role in reward- and
ddiction-related behavior. Transgenic mice that lack dopamine
ignaling die of starvation; this is linked to a loss of food-motivated
ehavior (Szczypka et al., 2001). The ventral tegmental area (VTA)
opamine pathway that projects to the nucleus accumbens (NAc)
f the ventral striatum is a key pathway involved in incentive
otivation. As reviewed elsewhere (Volkow et al., 2013), these
opamine neurons become activated after delivery of a novel food
eward (Norgren et al., 2006) but with repeated exposure to that
ame reward this activation lessens (habituates) and is induced
nstead by (predictive) cues associated with that reward (Epstein
t al., 2009; Schultz, 2010). Thus, dopamine signaling is crucially
mportant for the formation of associations between rewards and
he cues that predict their availability (Schultz et al., 1997; Stuber
t al., 2008; Salamone and Correa, 2012). Indeed, ﬁring of these
TA dopamine neurons has been suggested to signal the differ-
nce between expected rewards and the actual outcome, i.e. ahavioral Reviews 47 (2014) 295–306
reward-prediction error (Schultz et al., 1997; Cohen et al., 2012;
Steinberg et al., 2013; Boender et al., 2014). This signaling, which
involves dopamine release in the NAc, has also been suggested to
assign increasing reward value to food cues (Roitman et al., 2004).
After extensive training drug seeking becomes more cue-driven as
opposed to outcome-driven which is mediated by a transition from
dopaminergic activity in the ventral striatum (NAc core and shell)
to the dorsal striatum (caudate putamen) (Everitt and Robbins,
2005). It has been postulated that, via this mechanism, food cues
may  drive palatable food intake in a similar (habitual) fashion over
time (Smith and Robbins, 2013). In support of the importance
of dopaminergic projections to the NAc, blocking dopaminergic
neurotransmission in this target area has been shown to reduce
motivated behavior for reward, while local infusion of dopamine
agonists improves performance on tests of motivation in a similar
fashion to food restriction (Aberman et al., 1998).
Metabolic signals like leptin and ghrelin, which are primary reg-
ulators of homeostatic food consumption, also affect the hedonic
drive for food (e.g. Egecioglu et al., 2011) and a close relation-
ship between these signals and dopamine activity has been shown
experimentally. Domingos et al. (2011) recently showed that the
adipocyte-derived anorexigenic hormone leptin modulates the
reward value of sucrose. Whereas food-restriction increased the
rewarding value of sucrose in rats, treatment with leptin decreased
its value, presumably through the modulation of dopaminergic
activity. These data indicate that metabolic signals can inﬂuence
reward-related signaling and drive an animal to adapt motivated
behavior in response to changes in energy balance. Also, human
subjects with congenital leptin deﬁciency show increased activ-
ity of striatal areas in response to food-cues, but a reversal of this
activity following leptin treatment (Farooqi et al., 2007).
These data support earlier work showing that the striatal
dopaminergic reward system is sensitive to a range of hormones
associated with homeostatic control of food intake. In addition
to leptin (Fulton et al., 2006), the stomach-derived orexigenic
hormone ghrelin has been shown to have an important role in moti-
vation for food reward in rodents. Ghrelin increases lever-pressing
for sucrose in a progressive ratio operant responding paradigm
(Skibicka et al., 2012a), an effect that appears to involve the VTA-
accumbens dopaminergic pathway (Skibicka et al., 2013) as well
as mu-opioid-sensitive pathways (Skibicka et al., 2012b). Interest-
ingly, ghrelin’s effects on food reward behavior and simple intake
of chow exerted at the level of the VTA appear to be controlled by
divergent circuitry: although accumbens dopamine (Skibicka et al.,
2013) and VTA mu-opioid pathways (Skibicka et al., 2012b) have
an important role in food reward, they do not alter food intake. The
midbrain reward circuitry is also targeted by circulating anorex-
igenic peptides, several of which have been shown to suppress
food-motivated behavior, including GLP-1 (Dickson et al., 2012) and
insulin (Figlewicz et al., 2008).
Thus, recent diet history and metabolic signaling impinge upon
dopamine-driven motivational aspects of feeding behavior, and the
exact mechanisms are now beginning to be elucidated. A recent
review by van Zessen et al. (2012) described the evidence for lep-
tin and ghrelin’s actions on the VTA dopamine neurons either to
directly modulate dopamine release in target sites, or, like other
rewarding substances such as opiates and alcohol, act via GABAer-
gic neurons in the VTA. These metabolic hormones can also affect
other components of the brain’s reward pathway including neu-
rones projecting from the lateral hypothalamus, arcuate nucleus
and amygdala to the VTA (Narayanan et al., 2010).
But homeostatic signals can also affect circuitry that falls out-
side these motivation and pleasure-sensing pathways. For instance,
Berthoud (2011) pointed out that glucagon-like peptide-1 (GLP-
1) signaling might directly alter taste perception. Mice lacking
the GLP-1 receptor display reduced sensitivity to sweet tastes but
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ncreased sensitivity to umami  (Martin et al., 2009). Similarly, lep-
in receptor-deﬁcient mice display a heightened sense of smell, and
eptin itself, through its actions on leptin receptors expressed on
aste receptor cells themselves can alter the threshold for olfactory
timulation (Kawai et al., 2000). Such a direct interaction between
etabolic signals and taste perception might strongly affect food
hoice and subsequent intake.
In contrast to the mesolimbic dopamine system, which has been
inked to attention to and motivation for rewards, endogenous opi-
id systems have been linked to the pleasure associated with food
eward (Kelley et al., 2002). While opioids stimulate all food intake,
heir effects are particularly powerful for palatable food, especially
oods that are already preferred. This suggests that opioids rein-
orce an already established hedonic value (Gosnell et al., 1995;
lszewski et al., 2011). Previously, hedonic “hotspots” were deﬁned
n the brain where injections of opioid agonists produced pow-
rful “liking” responses in rats. These areas, which receive dense
opaminergic projections, include the medial shell of the NAc and
he ventral pallidum (Berridge, 1996; Pecin˜a et al., 2006; Pecin˜a,
008). At these sites, modulation of hedonic impact and feeding
ppear segregated, such that opioids do not affect feeding per se
Olszewski et al., 2011). In general, dopaminergic and opioid mech-
nisms seem to work together to promote food intake for which
opaminergic mechanisms promote the anticipation and the moti-
ation for food and opioids are involved in the consummation and
ossibly hedonic evaluation of food (Ackroff et al., 2010; Barbano
nd Cador, 2007; Oliveira-Maia et al., 2011).
Based on our current knowledge of the pathways involved in
he reward system and the mechanisms underlying its activation
e can merely speculate that subtle differences account for the
nter-individual and intra-individual variation of eating behavior.
hese differences can be due to genetic, epigenetic, psychological,
ocietal and environmental factors, some of which are interdepen-
ent. An eating addiction could thus be viewed as a rather strong
erturbation of single or several factors, that result in activation and
unction of the reward system. Both the industrialization and glob-
lisation of the food industry may  conceivably have contributed
o an increased risk of such a perturbation via the proliferation
f food related factors that render an individual prone to develop
uch an eating addiction. It is readily evident that the complexity
f the factors that shape individual eating behavior preclude an
ver-interpretation of speciﬁc ﬁndings including those of animal
odels.
. “Food addiction”, substance use disorders and eating
ehavior
.1. Food: substances of abuse?
Labeling a food or nutrient as “addictive” implies that it con-
ains ingredients and/or possesses an inherent property with the
apacity to make susceptible individuals addicted to it, as is the
ase for chemical substances of abuse. Certain foods have reward-
ng and reinforcing properties; for example, high sugar-high fat
ombinations are rewarding for rodents and humans alike. From
n evolutionary perspective, these rewarding properties increase
otivation to seek out and obtain an adequate and nutritionally
iverse energy supply. In our modern obesogenic environment,
haracterized by ready availability of highly palatable and energy-
ense food, it seems that these rewarding properties of particular
oods might overwhelm both cognitive restraint and homeostatic
echanisms, and lead to weight gain. Some have thus proposed
hat the recent increase in the prevalence of obesity reﬂects the
mergence of “food addiction” in a signiﬁcant fraction of the
opulation (Davis et al., 2011; Gearhardt et al., 2011). Indeed,havioral Reviews 47 (2014) 295–306 299
formulations of processed foods have been designed to maxi-
mize palatability and reward; globalization further promotes our
exposure to novel sensory combinations. Such properties are not
conﬁned to simple taste (sweetness, saltiness) but encompass more
complex blends of taste, ﬂavor, smell, texture and even the sounds
produced by preparation or consumption (Spence, 2012). However,
with the exception of caffeine (DSM-5 for the ﬁrst time refers to
Caffeine-Related Disorders within the category Substance-Related
and Addictive Disorders; APA, 2013), there is currently insufﬁcient
scientiﬁc evidence to label any common food, ingredient, micronu-
trient, standard food additive or combination of ingredients as
addictive.
Per se, foods are nutritionally complex and there is hardly any
evidence to suggest that under normal physiological circumstances
humans crave speciﬁc foods in order to ingest a speciﬁc ‘substance’.
Instead, the diet of subjects who overeat typically contains a broad
range of different, subjectively palatable foods. It can be argued that
access to a diversity of foods, especially a diverse range of palatable
foods, may  be a pre-requisite for the development of addictive-like
eating behavior. Therefore, one possible approach to overcome this
behavior would be to restrict access to only a small number of such
foods. Without access, it would be unlikely for such addictive-like
behaviors to be expressed. Furthermore, in overweight individuals,
this would likely entail a reduced energy intake, because the diver-
sity of rewarding, palatable foods is lacking.
3.2. The diagnosis “food addiction”
The Yale Food Addiction Scale (YFAS; Gearhardt et al., 2009)
can be viewed as the ﬁrst questionnaire to assess addictive eating
behavior based on the formal DSM-IV (APA, 2000) diagnostic crite-
ria for substance dependence. The naming of this questionnaire has
fueled the controversies related to “food addiction”. However, the
questionnaire clearly focuses on the assessment of eating behavior
and not on substance based addiction. Gearhardt and coworkers
described the YFAS as a “sound tool for identifying eating patterns
that are similar to behaviors seen in classic areas of addiction”. The
questionnaire includes 25 items which address eating habits over
the past 12 months. Examples include “I eat to the point where I
feel physically ill.”, and “I have had withdrawal symptoms such as
agitation, anxiety, or other physical symptoms when I cut down or
stopped eating certain foods.” Diagnosis of “food addiction” can be
made according to the DSM-IV criteria if at least three items out of
seven are fulﬁlled within the last 12 months and if the symptoms
additionally cause signiﬁcant distress to the patient or impairment
in social, occupational, or other important areas of functioning.
Despite the fact that the YFAS largely probes for palatable food
highly enriched with calories (e.g. chips, pizza, ice cream), it is
readily apparent that any of these foods comprises a host of dif-
ferent “substances”. Because the substance of abuse is not deﬁned,
the classiﬁcation of YFAS-diagnosed food addiction as a Substance
Use Disorder is not possible.
The YFAS criteria have been used to explore the prevalence
of ‘food addiction’ in obese subjects from the general population
(Davis et al., 2011, 2013) and clinical populations with (Gearhardt
et al., 2012, 2013a) and without Binge-Eating Disorder (BED) seek-
ing weight loss treatment (Burmeister et al., 2013; Clark and Saules,
2013; Eichen et al., 2013; Lent et al., 2014; Meule et al., 2012),
and from the general population of under-, normal and over-
weight/obesity (Flint et al., 2014; Gearhardt et al., 2009, 2013b;
Mason et al., 2013; Meule, 2012; Meule and Kübler, 2012; Murphy
et al., 2014; Pedram et al., 2013). In the latter study by Pedram and
colleagues, the prevalence rate of the YFAS diagnosis “food addic-
tion” is approximately 5%; females are affected twice as often as
males (6.7% vs. 3.0%; Pedram et al., 2013); in under/normal weight
or overweight/obese the rates of “food addiction” were 1.6% and
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.7%, respectively. In conclusion, “food addiction” is more common
n both obesity and BED, but can also occur independently of these
wo disorders.
The strict adherence to criteria used for Substance Related Disor-
ers presumably does not sufﬁce to fully capture the cognitions and
ehaviors of eating addiction. For example, for Gambling Disorder
peciﬁc criteria have been laid down in DSM-5 (APA, 2013), which
peciﬁcally address this addictive behavior and which only partially
est on those for Substance Related Disorders. Thus, disorder-
peciﬁc behavioral symptoms (see A criterion) include: “after losing
oney gambling, often returns another day to get even” or “relies
n others to provide money to relieve desperate ﬁnancial situations
aused by gambling”. In addition, for this behavioral addiction a
igher number of symptoms has to be met  in order to fulﬁll mild
4–5 symptoms), moderate (6–7) or severe (8–9) current severity
for alcohol use disorder the respective speciﬁcations are met  upon
resence of 2–3, 4–5, and 6 or more symptoms). Further research
s clearly warranted to phenotypically characterize subjects with
n eating addiction in an effort to in clinical terms fully delineate
his disorder and to eventually come up with stringent diagnos-
ic criteria. We  perceive the necessity, and at the same time the
ifﬁculty, to clearly separate known causes of overeating, which
ithout knowledge of the underlying process (e.g. leptin deﬁciency,
ypothalamic tumor) could be labeled as an addictive behavior. In
ight of the polygenic basis of BMI  variance in the general popu-
ation (Hinney and Hebebrand, 2008), we need studies to address
f addictive overeating (and obesity) can occur independently of a
enetic predisposition to an elevated body weight.
.3. Disentangling occasional overeating, binge eating and eating
ddiction
Davis (2013) proposed that overeating is a dimensional pro-
otype reﬂecting its severity, its degree of compulsiveness, and
ts clinically signiﬁcant level of personal impairment. Homeo-
tatic eating reﬂects a balance between energy intake and output;
passive overeating” entailing a slow but steady increase of body
eight reﬂects the inﬂuence of the obesogenic environment (e.g.
ortion size, overall availability of and easy access to highly palat-
ble energy dense foods) on susceptible individuals. Further down
he continuum, mild and intermittent “disinhibited eating” can
anifest as episodic binges. At this stage, clinical correlates of
disinhibited eating” include eating in the absence of hunger, emo-
ional eating and loss-of control eating (Tanofsky-Kraff et al., 2008;
annucci et al., 2013); if a threshold of severity and compulsive-
ess is exceeded, the diagnosis of BED may  be warranted (Davis,
013). Similarly, Alsiö et al. (2012) postulated a “feed-forward sys-
em”, according to which adaptations in both homeostatic and
on-homeostatic appetite regulation propel the individual from
 preference for palatable diets to food craving and compulsive,
ddiction-like eating behavior. According to Davis (2013) “food
ddiction” represents the extreme end of the continuum of overeat-
ng; she also suggests that “food addiction” reﬂects a subtype
f BED. Like “food addiction”, BED also occurs in normal weight
ndividuals albeit less frequently than in overweight or obese indi-
iduals.
In our opinion, the equation of “food addiction” with BED must
e viewed with caution. The impaired control over eating behavior
n “eating addiction” does not necessarily require that the affected
ndividual experiences a sense of lack of control over eating during
 single episode of overeating. In this context, the term “grazing”
an describe an unplanned and mindless eating behavior that can
ersist throughout the day, but which does not necessarily include
ating binges.
According to the current psychiatric classiﬁcation scheme, DSM-
, there is a phenomenological overlap between Substance-relatedhavioral Reviews 47 (2014) 295–306
and Addictive Disorders and Feeding and Eating Disorders (APA,
2013), in that ‘control’ plays a prominent role in the criteria for
disorders within these two categories. However, a closer look
reveals differences: thus, one of the central behavioral character-
istics of Substance Use Disorders (APA, 2013) is “impaired control”;
in addition, the DSM-5 introductory text for the overall category
Substance-Related and Addictive Disorders states that “. . .individuals
with lower levels of self-control, which may  reﬂect impairments of
brain inhibitory mechanisms, may  be particularly predisposed to
develop substance use disorders, suggesting that the roots of sub-
stance use disorders for some persons can be seen in behaviors long
before the onset of actual substance use itself”. In contrast, a “sense
of lack of control over eating during the (binge eating) episode” is
a key feature of both Bulimia Nervosa (BN) and BED (APA, 2013;
Albayrak et al., 2012). For the former diagnostic category the focus
is on the control of behavior before and after initial contact with a
substance, and subjective feelings of the loss of control are impor-
tant in the two eating disorders BN and BED. Accordingly, an outside
observer should be able to readily verify the impaired control of
subjects with substance use disorders. However, such an observer
would need to inquire if an individual affected with BN or BED
experiences the sense of lack of control over eating.
3.4. Vulnerable and high risk groups
Genetic factors are important in the development of substance
use disorders. For example, the heritability estimates of alcohol use
disorders or nicotine dependence are within the range of 40–60%.
Meta-analyses of genome-wide association studies have identiﬁed
non-overlapping genome-wide signiﬁcant signals for both alcohol
and nicotine dependence, which currently explain a small fraction
of the respective heritabilities (Wang et al., 2012). Twin or family
studies of “food addiction” have not yet been conducted. We  are
similarly not aware of a study that has systematically assessed the
relationship between socio-economic status and “food addiction”.
Based on its association with obesity, “food addiction” is presum-
ably more prevalent among subjects with low socio-economic
status. Alcohol dependence, smoking and illicit drug use have all
been associated with markers of social and economic disadvan-
tage (World Health Organization, 2003), as has problem gambling
(Welte et al., 2008).
In patients with Substance Use Disorders, psychiatric co-
morbidity is the rule rather than the exception, with mood, anxiety,
and conduct disorders being the most common co-morbid dis-
orders. Such disorders often precede the development of the
addiction, but can also develop after its onset. Models of bidi-
rectional relationships or contemporaneous combination of risk
factors have addressed this phenomenon (Mueser et al., 1998).
The likelihood of co-morbidity of mood or anxiety disorders is 2–3
times higher in adults with drug/alcohol dependency than in the
general population (Grant et al., 2004). Similarly, several psychi-
atric co-morbidities apply to behavioral addictions. For example,
pathological Internet use or Internet-dependent individuals have
elevated rates of depression and attention deﬁcit/hyperactivity dis-
order (ADHD) (Peukert et al., 2010).
Bellisle and coworkers (2012) summarize ﬁndings on subjects
who seemingly eat in the absence of hunger to induce reward.
This behavior is related to stress, especially in overweight individ-
uals with visceral adiposity, who may  have reward deﬁciency. The
YFAS has not yet been tested systematically in patients with men-
tal disorders; we  assume that similar to subjects with Substance
Use Disorders rates of “food addiction” are higher in individuals
who fulﬁll the diagnostic criteria for “food addiction”. Our own
studies of adolescent psychiatric in-patients revealed a high rate of
approximately 25% for a co-morbid diagnosis of “food addiction”,
with females being affected twice as often than males. The high
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ate of “food addiction” persisted after excluding patients with any
ating disorders (Albayrak et al., 2012), suggesting that addictive-
ike eating patterns might be associated with an adverse mental
ealth. Apart from the association with obesity, an overlap of “food
ddiction” with the eating disorder BED has been addressed in
dults. According to a recent study by Gearhardt et al. (2013a),
nly 41.5% of obese patients with BED met  the “food addiction”
hreshold, so neither obesity nor BED is synonymous with “food
ddiction”. Overweight BED patients with “food addiction” seem to
epresent a more severe subgroup than obese BED patients without
ood addiction in terms of emotional and eating behavior related
sychopathology (Gearhardt et al., 2012, 2013a). In a clinical sam-
le of obese BED patients, “food addiction” was  associated with
levated depression, negative affect, emotion dysregulation, eat-
ng disorder psychopathology and lower self-esteem (Gearhardt
t al., 2012). Thus, BED patients that additionally report symptoms
f “food addiction” may  be exhibiting a more disturbed variant of
ED, than those without.
. A critical review of rodent models of “food addiction”
Addiction research in general has accumulated substantial evi-
ence for the general translation of both pharmacological and
on-pharmacological results obtained in rodent models to humans
e.g. Xue et al., 2012; Planeta, 2013). In rat models of drug abuse, tol-
rance,  dependence and withdrawal are essential paradigms of the
ddictive properties of a given substance. Tolerance refers to the
ehavioral consequences of sub-cellular changes, such as receptor
esensitization or down-regulation (Ueda and Ueda, 2009), such
hat an increase in substance use is required to obtain the same
eurobiological effect. A necessary corollary of tolerance, therefore,
s an increase in intake. In rat models of food addiction, neither tol-
rance, nor an accompanying escalation of food intake, has been
onvincingly demonstrated. There are transient increases in intake
often described as “binges”), but the energy consumed is offset by
 reduction in food intake at other times, the net result being no
hange in body weight.
Physical dependence refers to adaptations to drug use that
ecome apparent after cessation of use. Abrupt abstinence results
n a withdrawal syndrome. This syndrome is best characterized in
piate dependence, which may  have a broader relevance, as some
echanisms underlying food addictions are suggested to involve
ndogenous opioids (Colantuoni et al., 2002). Opiate dependence
s manifested by a withdrawal syndrome that can also be triggered
y administration of the opiate antagonist naloxone (Wesson and
ing, 2003). Upon “withdrawal” of speciﬁc foods, few studies report
uch an analogous syndrome in rodents (Avena et al., 2008). Such
bservations have to our knowledge not been made in humans.
Despite the overall successful translation of several rodent
ddiction models to humans, it has been argued that it is over-
mbitious to attempt to model addiction in animals, and in rodents
n particular, where “validity” of such models is often restricted
o superﬁcial similarities, referred to as “face validity” that differ
ubstantially in terms of the underlying phenomena and biological
rocesses from the clinical situation (Stephens et al., 2013). Accord-
ngly, caution is also warranted for translating results obtained in
odent models of “food addiction” to humans. Thus, rodents are
sually offered single food substances or very simple combinations.
ased on such simplistic experiments we need to critically reﬂect,
f and to what degree these models of addiction resemble patterns
f eating behavior and food choice in humans. It again needs to be
tressed that humans tend not to eat speciﬁc nutrients in isolation.
hile rat experiments on, for instance, “sugar addiction” are neces-
ary to understand how a single nutrient may  affect neurobiologyhavioral Reviews 47 (2014) 295–306 301
and behavior, it is arguable whether they are directly relevant for
human pathology.
The mere involvement of endogenous opioid systems in the reg-
ulation of food intake does not in itself imply that over-activation
of these pathways through excessive eating will result in depend-
ence on endogenous opioids. The opioid pathway that regulates
food intake via hypothalamic oxytocin neurons mediates satiety,
and is extremely sensitive to inhibition by exogenous opioids. In
rats treated chronically with morphine, oxytocin neurons exhibit
both tolerance (i.e. a markedly increased threshold to inhibition by
morphine) and dependence (as evidenced by a massive and pro-
longed hypersecretion of oxytocin when morphine withdrawal is
acutely provoked by naloxone (Brown et al., 2005)). Accordingly,
if the endogenous opioid pathways that regulate oxytocin neu-
rons are activated by the consumption of rewarding food, then an
expected consequence would be suppression of satiety leading to
overconsumption. However, we  would expect that this mechanism
would be down-regulated in response to chronic overconsumption
(tolerance), and that, if it indeed resulted in endogenous opioid
dependence, then fasting should precipitate a hypersecretion of
oxytocin with a resulting prolonged potentiation of satiety (with-
drawal). To date, this hypothesis has not been tested.
There is currently no evidence that single nutritional substances
can elicit a Substance Use Disorder in humans according to DSM 5
criteria. In light of the lack of clinical studies that have aimed to
detect addictions to speciﬁc nutrients, it cannot as yet be ruled out
that a predisposed subgroup does indeed develop such a substance
based addiction, which in theory may  be substantially weaker than
in the case of addictions based on well-known exogenous sub-
stances such as alcohol, cannabis, nicotine or opiates. The fact, that
clinical case studies do not abound on an addiction like intake of
speciﬁc nutrients or even speciﬁc foods, would suggest that such
cases are rare, if they exist at all. Alternatively, the addiction is
so weak that it is not adequately perceived and reported as such.
This leads to the question as to the boundaries between excessive
consumption and the beginning of a true addiction.
Animal studies have been performed using palatable food as
a stimulus, and some of these foods do appear able to induce
an addiction-like phenotype. In rodents, characteristics of food
linked to taste and palatability seem to be especially important
for the expression of some addiction-like behaviors, including
binge-eating. Withdrawal-like behaviors have been reported after
terminating access to sugar (Colantuoni et al., 2002). As a sur-
rogate for craving, it is possible to show enhanced motivation
for sucrose in rats during periods of abstinence – the rats work
increasingly hard (by repeatedly pressing a lever) to obtain sucrose
pellet rewards. In this respect it is also noteworthy to mention
that a majority of rats will prefer a sweet reward over a cocaine
reward and only a subset of rats will start to prefer cocaine after
an extended history of cocaine self-administration (Lenoir et al.,
2007). Findings such as these suggest that rats can become strongly
motivated to consume certain foods. Thus, it is possible that
addictive-like behavior can be manifest, usually, but not always,
directed toward foods high in fat and/or sugar (Kaplan, 1996). The
study of foods as substances that can be abused is in its early stages.
However, it has been shown that rats exposed to the so-called
“cafeteria diet” (composed of numerous nutrient combinations in
the form of common palatable foods like bacon, cheesecake, and
chocolate) develop an apparent compulsivity toward palatable food
consumption, a process which may  mirror impaired control – a
hallmark of addictive behavior (Johnson and Kenny, 2010).
Impaired control is a common phenomenon seen in addictive
behaviors. Besides an increased motivation to work for a food
reward after extended access to the rewarding substance, rats will
seek the reward, even when it is signaled to them that the reward
is unavailable. Moreover, after an extended history of cocaine
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elf-administration, rats will continue to press a lever to obtain a
ocaine infusion when a tone is presented that is previously asso-
iated with a foot shock (Deroche-Gamonet et al., 2004; Pelloux
t al., 2007; Vanderschuren and Everitt, 2004). When compared to
ocaine, rats are less motivated to work for a chocolate drink and in
ontrast to cocaine will not seek the chocolate drink when a tone
s presented that was previously associated with a foot shock, even
fter being exposed to palatable diets for 2 months (de Jong et al.,
013; but see: Johnson and Kenny, 2010). Although some rats may
isplay a tendency to display addictive-like behaviors, exposure to
alatable foods high in fat and sugar, did not result increase these
ehaviors as observed after extended access to cocaine (de Jong
t al., 2013).
.1. Sugar addiction
In all aerobic cells, sugars are subjected to glycolysis to produce
yruvate – the fundamental substrate used to generate chemical
nergy in the citric acid cycle. As such, mono-, di- and polysaccha-
ides are essential components of our diet. Animals have specialized
enses that allow them to readily detect the presence of mono- and
isaccharides in potential food sources, and humans perceive these
ubstances as sweet. Rats also prefer sweet-tasting sugar solutions,
nd solutions of artiﬁcial sweeteners perceived as having equiv-
lent sweetness, across a broad range of concentrations without
rior training (Sclafani, 1987). Thus, there seems to be an innate
or a quickly learned) motivation to consume sweet foods.
Apart from a single case study (Thornley and McRobbie, 2009),
ddiction-related behaviors in sugar consumption (such as tol-
rance and a withdrawal syndrome) have not been observed in
umans (Benton, 2010). Instead, most observational and mech-
nistic evidence for addiction to sugar comes from rat models
ioneered in Bart Hoebel’s laboratory (Avena et al., 2008). A variety
f subtly different approaches have been taken, but most studies
nvolve examining feeding behavior during intermittent access to
alatable sugar solutions. For example, repeated 12 h food depri-
ation followed by 12 h intermittent access to normal food and a
ugar solution leads to sugar “binging” (deﬁned operationally as
n increased intake compared to rats offered unrestricted access
ver the same time period). Furthermore, there is evidence that
ndogenous opioid signaling is active during sugar (but not fat;
ocarsly et al., 2011) binging, as i.p. administration of the opioid
eceptor antagonist, naloxone, results in somatic effects reminis-
ent of a withdrawal syndrome (Colantuoni et al., 2002). It was
uggested that sugar recruits endogenous opioid pathways, with
onsequences analogous to those that follow consumption of drugs
f abuse. However, these data do not imply that these pathways are
eing activated by a substance.  Certain behaviors can also recruit
ndogenous opioid systems. For example, rats subjected to food
estriction and given 1hr/day access to a running wheel show a
ithdrawal syndrome on naloxone administration, whereas much
eaker withdrawal-like behaviors were seen in food-restricted
r pair-fed rats not given access to a running wheel (Kanarek
t al., 2009). The underlying endocrine mechanisms relevant in this
odel which has been used to explain the hyperactivity of patients
ith acute anorexia nervosa go well beyond the opioid system and
nclude an activation of the hypothalamus-pituitary-adrenal axis
nduced via hypoleptinemia (Hebebrand et al., 2003); adrenalec-
omy (Duclos et al., 2009) or exogenous application of leptin (Exner
t al., 2000) prevents the development of hyperactivity upon food
estriction. This complex model indicates that the combination of
n environmental effect (running wheel) with a speciﬁc temporal
attern of food restriction entails both a speciﬁc behavior (hyper-
ctivity) and profound neuroendocrine alterations that include the
ngagement of the endogenous opioid system in a manner anal-
gous to opiate drugs of abuse. Thus, under speciﬁc conditionshavioral Reviews 47 (2014) 295–306
addictive-like responses may  be attributed not just to substances
but also to behaviors. Alternatively, a behavior may  become addic-
tive because of the system(s) it activates. In the context of sugar
addiction, a behavioral addiction rather than an addiction to a
substance also warrants consideration as an explanation for the
observations made in the respective experiments.
Other models that evoke binging include a diet and stress model
where cycles of food restriction and refeeding with palatable food
are paired with acute stressors (Hagan et al., 2002). Given that this
model explicitly uses a stressor and others use regular food depriva-
tion (also a physiological stressor), these paradigms may  represent
a form of stress-evoked eating (Maniam and Morris, 2012). It is
worth noting that in most of these sugar addiction models rats do
not become obese. These rats down-regulate their energy intake
from other sources and maintain a stable body weight (Avena et al.,
2012), leading to the hypothesis that sugar addiction in humans – if
it occurs at all – may  not be relevant for the development of obesity.
Since normal food intake is reduced after binges and weight gain
does not occur, homeostatic mechanisms are preserved, it could
be argued that these paradigms may  better represent a form of
binge-eating driven by intermittent access to hedonic stimuli.
In humans, addictive behavior is often accompanied by com-
plex psychological/psychiatric constructs like memory, boredom,
shame, guilt, habit, impulsivity, restraint, depression and anxi-
ety. Undoubtedly, these contribute to behavioral addiction but
this further layer of complexity is difﬁcult to model in rats
(Packard, 2009). Based on a rat model for cocaine-craving behav-
ior (Grimm et al., 2001), Grimm and co-workers showed that
rats responded to a tone + light cue previously associated with
10% sucrose self-administration; lever pressing during tests for
resistance to extinction and cue-induced reinstatement of sucrose
seeking in rats progressively increased over the ﬁrst 2 months of
withdrawal (Grimm et al., 2002). Environmental enrichment such
as grouping four animals in a large environment with novel objects
has been shown to strongly attenuate cue-induced reinstatement
of sucrose seeking (Grimm et al., 2008). The beneﬁcial effect of
an enriched environment on substance addiction in rodents has
led Solinas and coworkers (2008) to suggest that in addition to
cognitive and behavioral interventions to target craving-inducing
situations, a positive and stimulating environment per se could
facilitate abstinence.
4.2. Fat addiction
Maintenance of normal body function requires an adequate
daily intake of fat, and the general advice is that a healthy diet
should contain about 20–35% fat (Institute of Medicine, 2005).
Of note, fat content in the diet improves the palatability of food,
through taste, texture and oro-sensory experience in most mam-
mals, including humans, who  generally prefer high-fat food to
low-fat food. It is unclear to what extent dietary fat is a basic tastant;
fatty acid chemoreception has been observed in humans (Newman
et al., 2013). Although the evidence is incomplete, it is thought that
dietary lipids are detected by a combination of oro-sensory percep-
tion, retronasal olfactory and post-ingestive cues (Mizushige et al.,
2007). Deciphering the chemical and molecular network within the
oral cavity, gastrointestinal tract, hormonal signals and the CNS, all
of which are implicated in the palatability and perception of dietary
lipids remains as a major challenge.
Because the central effects of many signals involved in energy
homeostasis, including leptin, ghrelin, MCH  and GLP-1, are
markedly inﬂuenced by intake of high fat diets, the occurrence of
addictive-like behaviors in animals exposed to these diets is not
surprising. Mice exposed to ad libitum fat-rich food exhibit signs
of anxiety and willingness to endure an aversive environment in
order to gain access to the high-fat food, as well as neurochemical
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hanges in signals related to reward (Teegarden and Bale, 2007;
eegarden et al., 2008). Mice exposed to preferred diets high in fat
ave decreased stress sensitivity, whereas acute withdrawal from
uch a diet elevates the stress state and reduces reward (Teegarden
nd Bale, 2007; Teegarden et al., 2008).
Experiments with binge-type overeating similar to that
escribed above for sugar have been undertaken by different
roups. Although some of the neurochemical changes elicited by
at binging appear to be similar to changes elicited by sugar intake
e.g. dopamine release in the NAc; Liang et al., 2006), no signs of
piate-like withdrawal in fat-binging rats were detected (Avena,
010). In contrast, rats identiﬁed as prone to binge-eating will
olerate higher levels of foot shock when it is paired with a fat-
ontaining food, suggesting that binge eating can be associated with
n abnormal motivation to consume palatable food (Avena, 2010).
he effects appear to depend on the experimental model, being
ore evident when rats are exposed to calorie restriction or stress
xposure (Pankevich et al., 2010). Again, the same limitations apply
s described above in relation to sucrose. Finally, and in contrast to
ugar addiction models, an important confounding factor is that
igh-fat diets lead to weight gain and increased adiposity. There-
ore, in some instances it is difﬁcult to ascertain which changes are
ust a consequence of increased adiposity and weight, and which
re speciﬁcally associated with the intake of fat-rich diets.
.3. Salt addiction
Salt improves ﬂavor perception and so-called “hidden” salt is
ften added to foods in relatively high amounts before they reach
he table; this even applies to foods perceived by consumers as
ealthy (Magriplis et al., 2011). Often, despite containing no calo-
ies, salt is consumed beyond physiological need. In a healthy
ndividual excess salt intake can be diluted by additional ﬂuid
ntake, while ultimately the kidneys eliminate excess sodium (and
xcess water) in urine through natriuretic and diuretic mecha-
isms. Thus salt intake stimulates ﬂuid intake – and if the most
eadily available and palatable ﬂuid is energy dense, this can
ontribute to increased calorie intake. Accordingly if salt itself
ere addictive, this might promote excessive calorie intake, either
irectly (by promoting intake of salty energy-dense foods) or as an
piphenomenon (by promoting intake of energy dense ﬂuids).
Evidence for an innate Na+ (but not NaCl) appetite is very strong
n rats. It is driven by hypotonic ﬂuid intake or electrolyte loss,
nd is a distinct homeostatic process, involving well-deﬁned brain
egions – notably the subfornical organ, and speciﬁc endogenous
europeptide messengers (Bertino and Tordoff, 1988). However,
he role of salt in increasing directly the rewarding value of food
s relatively unexplored. An aversion to high concentrations of
ietary salt in rats can be reversed by Na+-depletion, via mecha-
isms involving activation of the reward pathway (Robinson and
erridge, 2013). A -opioid receptor agonist increases salt con-
umption after infusion into the NAc (Zhang and Kelley, 2002) and
alt consumption competes with electrical stimulation of the lateral
ypothalamus in a forced-choice preference test in Na+-depleted
ats (Conover et al., 1994). However, an increased taste preference
or salt is not observed in Na+-depleted rats (Clark and Bernstein,
006) and lesions of VTA dopamine neurons does not alter Na+ con-
umption in Na+-replete rats (Shibata et al., 2009). Thus it is possible
hat salt reward may  occur only in the depleted state and reﬂects
hanges in motivation rather than an increased preference for a
alty taste.
In contrast to rats, Na+-deﬁcient humans do not generally seek
o increase their salt intake (Leshem, 2009). Whereas humans have
 strong preference for sweet tastes, a strong salt preference may
ot be innate to humans. Very young children do not discrimi-
ate between isotonic salt solutions and water suggesting eitherhavioral Reviews 47 (2014) 295–306 303
that they do not detect salt or that they ﬁnd the solutions equally
palatable. However, a preference toward salt solutions develops in
young children only to then disappear between the ages of 3 and 5.
From this age on, humans do not ﬁnd simple salt solutions palat-
able but rather aversive (Beauchamp et al., 1986). Thus, a strong salt
preference is not evident across most of the life-span. As with sweet
or fat tasting foods the distinct enjoyment of salty ﬂavored foods in
many humans may  result from conditioned learning in association
with other ﬂavor preferences, rather than having a hedonic drive to
consume salt or Na+. Some rodent studies describe a link between
salt intake and reward centers in the brain, but there is little evi-
dence that salt has reinforcing properties unless in conditions of salt
depletion (Berridge et al., 1984; Tekol, 2006). Perhaps the distinct
enjoyment of salty ﬂavored foods in humans is a result of condi-
tioned learning in association with other ﬂavor preferences, rather
than having a hedonic drive to consume salt or Na+. Nonetheless,
it is unclear whether salt can increase the rewarding properties of
food and what physiological consequences this might have.
5. Conclusions
The term ‘food addiction’ is now a part of everyday language.
Vocabulary such as “chocoholic” (in use since the 1960s) and
“craving” – used to refer to a person’s desire and fondness for
food – is in common use, and many people believe these conditions
approach the severity of an addiction (Bird et al., 2013). Undoubt-
edly, some people believe that their relationship with problem
foods constitutes an addiction, and engage with treatment regi-
mens or approach help groups such as Food Addicts Anonymous –
established in 1987. With addiction-related terminology in com-
mon use, and treatment, support and recipe books available for
“food addicts” it is unsurprising that the media have accepted “food
addiction” as fact, with one broadcaster (BBC), for example, hav-
ing more than 40 news stories related to “food addiction” on its
website.
We concur with Hone-Blanchet and Fecteau (2014) that it is
premature to conclude validity of the food addiction phenotype
in humans from the current behavioral and neurobiological evi-
dence gained in rodent models. Humans who overeat usually do
not restrict their diets to speciﬁc nutrients; instead the availabil-
ity of a wider range of palatable foods appears to render prone
subjects vulnerable to overeating. Undoubtedly, the food industry
needs to act responsibly given that easy access to highly palatable
and calorie dense foods promotes overeating and potentially the
development of an “eating addiction” in predisposed individuals.
It may  ultimately be for governments to take action and regulate
the food industry, by requesting informative labels and restricting
advertising (Bagaric and Erbacher, 2005). At the same time, the
medical ﬁeld, and in particular psychiatry and clinical psychology,
should continue to research “eating addiction”. In retrospect, the
medicalization of tobacco use has proven extremely important in
promoting large scale, individual-based, and structural prevention
programs, which have successfully led to a reduction in the pro-
portion of adolescents and adults who smoke (Schaap et al., 2008;
Levy et al., 2010; White et al., 2011).
To conclude, the society as a whole should be aware of the
differences between addiction in the context of substance use
versus an addictive behavior. As we  pointed out in this review,
there is very little evidence to indicate that humans can develop
a “Glucose/Sucrose/Fructose Use Disorder” as a diagnosis within
the DSM-5 category Substance Use Disorders. We  do, however,
view both rodent and human data as consistent with the existence
of addictive eating behavior. The new DSM-5 (APA, 2013) cur-
rently does not allow the classiﬁcation of an “Overeating Disorder”
or an “Addictive Eating Disorder” within the diagnostic category
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ubstance-Related and Addictive Disorders; indeed, the current
nowledge of addictive eating behaviors does not warrant such a
iagnosis. However, efforts should be made to operationalize the
iagnostic criteria for such a disorder and to test its reliability and
alidity. It needs to be determined if such a disorder can occur
istinct from other mental disorders.
Currently, the assessment of “food addiction” mainly relies on
he YFAS questionnaire, which is based on the diagnostic criteria
f substance dependence according to DSM-IV (Gearhardt et al.,
009). In our opinion, the term “Eating Addiction” or “Addic-
ive Eating Disorder” would have been more appropriate to avoid
he unsubstantiated connotation that food contains chemical sub-
tances that can lead to the development of a Substance Use Disorder.
e have pointed out that the mere application of the criteria used
o deﬁne substance dependence does not likely appear sufﬁcient
o fully capture the phenomenological aspects of an eating addic-
ion. As illustrated above, we are aware of the vague distinctions
etween substance-based and behavioral-based addictions. Nev-
rtheless, we view the current evidence as being more in favor of
ddictive-like behaviors to describe the phenomenon of continuous
vereating of a variety of foods.
We perceive the need to disentangle the mechanisms under-
ying an “eating addiction” with and without obesity. The
ifferentiation of subjects who overeat due to increased hunger
nd/or a reduced satiety from those with an “eating addiction”
ppears difﬁcult; research is required to uncover biological, physi-
logical, and psychological differences. Obviously, twin and family
tudies are required to assess heritability of “eating addiction” (or
ifferent subgroups of “eating addiction”). Given the increasing
umber of gene variants known to contribute to the variance in
ody mass index (BMI; kg/m2) in the general population, it will
e of interest to genotype normal weight and obese subjects with
nd without “eating addiction” to assess whether the frequencies of
elevant alleles differ. As progress is made in uncovering alleles pre-
isposing to diverse substance use disorders or addictive disorders,
he overlap with “eating addiction” can be assessed.
Although the scientiﬁc discussion about “eating addiction” is
n its infancy, it has a potentially large public health impact on
reatment and prevention strategies. Ultimately, politicians and
ndustrial stakeholders need to be involved in ﬁnding solutions
o overcome the potential risk of becoming “eating addicted” to
ndustrially processed food highly enriched with carbohydrates,
alt or fat. Given that the “food addiction genie” is out of the
ottle, the best strategy may  be to engage with the public in a
ebate centering on addictive behavior as a cause of overeating
nd obesity. We  must make clear that there is no evidence that
food addiction” can be considered as a Substance Use Disorder. We
gree with Stice and coworkers (2013), who have recently sug-
ested that it might be more useful to focus on overeating as a
orm of food ‘abuse’; however, as pointed out above, the diagno-
is of a (substance) abuse has been dropped in DSM-V. Stressing
food addiction” as an addiction to eating must be viewed critically,
ecause this focus does not convey an unambiguous and helpful
essage that is supported by available evidence. Accordingly, we
elieve that a diagnosis of “eating addiction” is superior to “food
ddiction” for educational purposes. “Eating addiction” stresses the
ehavioral component, whereas “food addiction” appears more like
 passive process which simply befalls an individual.
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